Evidence map›Paper›PMID 41644941›Full record

ArticleNature communications2026

Author Correction: Dual-targeted siRubicon delivery strategy triggers hepatocellular lipophagy for mitigating liver steatosis.

Tingting Lan, Qiushi Li, Mingxing Yu, Xu Duan, Tao Ming, Shuo Li, Chunjiong Wang, Yi Zhu, Zhongyang Shen, Deling Kong and 1 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Tingting Lan *Research Institute of Transplant Medicine, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.ORCID http://orcid.org/0000-0002-4865-4092
Qiushi Li *State Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Functional Polymer Materials of Ministry of Education, College of Chemistry, Frontiers Science Center for New Organic Matter, Nankai University, Tianjin, China.
Mingxing YuResearch Institute of Transplant Medicine, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
Xu DuanResearch Institute of Transplant Medicine, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
Tao MingResearch Institute of Transplant Medicine, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
Shuo LiResearch Institute of Transplant Medicine, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China.
Chunjiong WangDepartment of Physiology and Pathophysiology, Tianjin Medical University, Tianjin, China.ORCID http://orcid.org/0000-0001-7464-267X
Yi ZhuDepartment of Physiology and Pathophysiology, Tianjin Medical University, Tianjin, China.ORCID http://orcid.org/0000-0001-7725-9166
Zhongyang ShenResearch Institute of Transplant Medicine, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China. zhongyangshen@nankai.edu.cn.ORCID http://orcid.org/0009-0000-2212-4539
Deling KongResearch Institute of Transplant Medicine, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China. kongdeling@nankai.edu.cn.ORCID http://orcid.org/0000-0002-2961-9267
Yang LiuState Key Laboratory of Medicinal Chemical Biology, Key Laboratory of Functional Polymer Materials of Ministry of Education, College of Chemistry, Frontiers Science Center for New Organic Matter, Nankai University, Tianjin, China. yliu@nankai.edu.cn.ORCID http://orcid.org/0000-0001-5752-5180

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41644941
PMCPMC12877169

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.